Dextroamphetamine 109ing 64 Hours of Sustained Wakefulness: A Simulator Study.”Aviation, Space, and
Environmental Medicine71 (2000): 7–18.
Domino, E.F., et al. “Effects of D-Amphetamine on Quantitative Measures of Motor
Performance.”Clinical Pharmacology and Therapeutics13 (1972): 251–57.
Emonson, D.L., and R.D. Vanderbeek. “The Use of Amphetamines in U.S. Air Force
Tactical Operations during Desert Shield and Storm.”Aviation, Space, and Envi-
ronmental Medicine66 (1995): 260–63.
Graybiel, A. “Space Motion Sickness: Skylab Revisited.”Aviation, Space, and Environ-
mental Medicine51 (1980): 814–22.
Griffith, J.D., et al. “Dextroamphetamine.”Archives of General Psychiatry26 (1972): 97–
100.
Jacobs, D., and T. Silverstone. “Dextroamphetamine-Induced Arousal in Human Sub-
jects as a Model for Mania.”Psychological Medicine16 (1986): 323–29.
Jasinski, D.R., and K.L. Preston. “Evaluation of Mixtures of Morphine and D-
Amphetamine for Subjective and Physiological Effects.”Drug and Alcohol Depen-
dence17 (1986): 1–13.
Ward, A.S., et al. “Effects of D-Amphetamine on Task Performance and Social Behavior
of Humans in a Residential Laboratory.”Experimental and Clinical Psychophar-
macology5 (1997): 130–36.